Inducible Lentivirus-Mediated siRNA against TLR4 Reduces Nociception in a Rat Model of Bone Cancer Pain

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Pan, Ruirui ^a   Di, Huiting ^a   Zhang, Jinming ^a   Huang, Zhangxiang ^a,b   Sun, Yuming ^a   Yu, Weifeng ^a   Wu, Feixiang ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b KUNMING GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; INTERLEUKIN 1BETA; MESSENGER RNA; SMALL INTERFERING RNA; TETRACYCLINE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; DOXORUBICIN; TLR4 PROTEIN, RAT; TUMOR NECROSIS FACTOR;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; BONE CANCER; CANCER PAIN; CANCER TRANSPLANTATION; CONTROLLED STUDY; DRUG EFFECT; DRUG SYNTHESIS; DRUG TARGETING; LENTIVIRINAE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL CORD; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; BONE TUMOR; COMPLICATION; DISEASE MODEL; GENETICS; PAIN, INTRACTABLE; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BONE NEOPLASMS; DISEASE MODELS, ANIMAL; DOXORUBICIN; INTERLEUKIN-1BETA; LENTIVIRUS; NOCICEPTION; PAIN, INTRACTABLE; RATS; RNA, SMALL INTERFERING; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84947976506     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/523896     Document Type: Article

References (36)

1. P. Strang, "Cancer pain - a provoker of emotional, social and existential distress," Acta Oncologica, vol. 37, no. 7-8, pp. 641-644, 1998.
2. T. Kinzel, "Symptom control in geriatric patients with terminal cancer: pain, nausea, and vomiting," Geriatrics, vol. 43, no. 6, pp. 83-89, 1988.
3. P. Honore, S. D. Rogers, M. J. Schwei et al., "Murinemodels of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons," Neuroscience, vol. 98, no. 3, pp. 585-598, 2000.
4. M. J. Schwei, P. Honore, S. D. Rogers et al., "Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain," Journal of Neuroscience, vol. 19, no. 24, pp. 10886-10897, 1999.
5. L. R. Watkins, E. D. Milligan, and S. F. Maier, "Glial activation: a driving force for pathological pain," Trends in Neurosciences, vol. 24, no. 8, pp. 450-455, 2001.
6. L. S. Lan, Y. J. Ping, W.L. Na et al., "Down-regulationofToll-like receptor 4 gene expression by short interfering RNA attenuates bone cancer pain in a rat model," Molecular Pain, vol. 6, article 2, 2010.
7. I. Bettoni, F. Comelli, C. Rossini et al., "Glial TLR4 receptor as new target to treat neuropathic pain: efficacy of a new receptor antagonist in a model of peripheral nerve injury in mice," Glia, vol. 56, no. 12, pp. 1312-1319, 2008.
8. T. Sun, J. Luo, M. Jia, H. Li, K. Li, and Z. Fu, "Small interfering RNA-mediated knockdown of NF-κBp65 attenuates neuropathic pain following peripheral nerve injury in rats," European Journal of Pharmacology, vol. 682, no. 1-3, pp. 79-85, 2012.
9. F.-X. Wu, J.-J. Bian, X.-R. Miao et al., "Intrathecal siRNA against toll-like receptor 4 reduces nociception in a rat model of neuropathic pain," International Journal ofMedical Sciences, vol. 7, no. 5, pp. 251-259, 2010.
10. S. C. Barry, B. Harder, M. Brzezinski, L. Y. Flint, J. Seppen, and W. R. A. Osborne, "Lentivirus vectors encoding both central polypurine tract and posttranscriptional regulatory element provide enhanced transduction and transgene expression," Human GeneTherapy, vol. 12, no. 9, pp. 1103-1108, 2001.
11. D. Wübbenhorst, K. Dumler, B. Wagner et al., "Tetracyclineregulated bone morphogenetic protein 2 gene expression in lentivirally transduced primary rabbit chondrocytes for treatment of cartilage defects," Arthritis and Rheumatism, vol. 62, no. 7, pp. 2037-2046, 2010.
12. X.-R. Miao, X.-F. Gao, J.-X. Wu et al., "Bilateral downregulation of Nav1.8 in dorsal root ganglia of rats with bone cancer pain induced by inoculation with Walker 256 breast tumor cells," BMC Cancer, vol. 10, article 216, 2010.
13. R. V. Størkson, A. Kjørsvik, A. Tjølsen, and K. Hole, "Lumbar catheterization of the spinal subarachnoid space in the rat," Journal ofNeuroscienceMethods, vol. 65, no. 2, pp. 167-172, 1996.
14. E.D. Milligan, J. L. Hinde, K. K. Mehmert, S. F. Maier, and L.R. Watkins, "A method for increasing the viability of the external portion of lumbar catheters placed in the spinal subarachnoid space of rats," Journal of NeuroscienceMethods, vol. 90, no. 1, pp. 81-86, 1999.
15. F. Wu, Y. Liu, X. Lv, X. Miao, Y. Sun, and W. Yu, "Small interference RNA targeting TLR4 gene effectively attenuates pulmonary inflammation in a rat model," Journal of Biomedicine and Biotechnology, vol. 2012, Article ID 406435, 8 pages, 2012.
16. G. An, T.-N. Lin, J.-S. Liu, J.-J. Xue, Y.-Y. He, and C. Y. Hsu, "Expression of c-fos and c-jun family genes after focal cerebral ischemia," Annals of Neurology, vol. 33, no. 5, pp. 457-464, 1993.
17. E. D. Milligan, C. Twining, M. Chacur et al., "Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats,"The Journal of Neuroscience, vol. 23, no. 3, pp. 1026-1040, 2003.
18. M. M. Bradford, "A rapid and sensitive method for the quantitation ofmicrogram quantities of protein utilizing the principle of protein-dye binding," Analytical Biochemistry, vol. 72, no. 1-2, pp. 248-254, 1976.
19. C. Lu, Y. Liu, B. Sun et al., "Intrathecal injection of JWH-015 attenuates bone cancer pain via time-dependentmodification of pro-inflammatory cytokines expression and astrocytes activity in spinal cord," Inflammation, 2015.
20. E. Csullog, G. Joo, G. Toth, I. Dobos, G. Benedek, and G. Horvath, "Antinociceptive effect of continuous intrathecal administration of endomorphin-1," Pain, vol. 94, no. 1, pp. 31-38, 2001.
21. I. L. Calil, A. C. Zarpelon, A. T. G. Guerrero et al., "Lipopolysaccharide induces inflammatory hyperalgesia triggering a TLR4/MyD88-dependent cytokine cascade in the mice paw," PLoS ONE, vol. 9, no. 3, Article ID e90013, 2014.
22. R.-J. Chen, H.-H. Yuan, T.-Y. Zhang et al., "Heme oxygenase-2 suppress TNF-α and IL6 expression via TLR4/MyD88-dependent signaling pathway in mouse cerebral vascular endothelial cells," Molecular Neurobiology, vol. 50, no. 3, pp. 971-978, 2014.
23. M. Ray, S. Yu, D. R. Sharda et al., "Inhibition of TLR4-induced IκB kinase activity by the RON receptor tyrosine kinase and its ligand, macrophage-stimulating protein," The Journal of Immunology, vol. 185, no. 12, pp. 7309-7316, 2010.
24. S. Lehnard, C. Lachance, S. Patrizi et al., "The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS," The Journal of Neuroscience, vol. 22, no. 7, pp. 2478-2486, 2002.
25. Y.-Q. Ma, Y.-R. Chen, Y.-F. Leng, and Z.-W. Wu, "Tanshinone IIA downregulates HMGB1 and TLR4 expression in a spinal nerve ligation model of neuropathic pain," Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 639563, 8 pages, 2014.
26. M. R. Hutchinson, Y. Zhang, K. Brown et al., "Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4)," European Journal of Neuroscience, vol. 28, no. 1, pp. 20-29, 2008.
27. S. Gupta, R. A. Schoer, J. E. Egan, G. J. Hannon, and V. Mittal, "Inducible, reversible, and stable RNA interference in mammalian cells," Proceedings of the National Academy of Sciences of theUnited States ofAmerica, vol. 101, no.7, pp. 1927-1932, 2004.
28. M. Pan, J. Ni, H. He, S. Gao, and X. Duan, "New paradigms on siRNA local application," BMB Reports, vol. 48, no. 3, pp. 147-152, 2015.
29. M.-C. Luo, D.-Q. Zhang, S.-W. Ma et al., "An efficient intrathecal delivery of small interfering RNA to the spinal cord and peripheral neurons," Molecular Pain, vol. 1, article 29, 2005.
30. A. Meunier and M. Pohl, "Lentiviral vectors for gene transfer into the spinal cord glial cells," GeneTherapy, vol. 16, no. 4, pp. 476-482, 2009.
31. F. Wu, R. Pan, J. Chen et al., "LentivirusmediatedsiRNAagainst GluN2B subunit ofNMDAreceptor reduces nociception in a rat model of neuropathic pain," BioMed Research International, vol. 2014, Article ID 871637, 7 pages, 2014.
32. Y.-K. Zhang, J.-T. Liu, Z.-W. Peng et al., "Different TLR4 expression and microglia/macrophage activation induced by hemorrhage in the rat spinal cord after compressive injury," Journal of Neuroinflammation, vol. 10, article 112, 2013.
33. A. Welman, J. Barraclough, and C. Dive, "Tetracycline regulated systems in functional oncogenomics," Translational Oncogenomics, vol. 2, pp. 17-33, 2007.
34. A. Tauch, A. Pühler, J. Kalinowski, and G. Thierbach, "TetZ, a new tetracycline resistance determinant discovered in grampositive bacteria, shows high homology to gram-negative regulated efflux systems," Plasmid, vol. 44, no. 3, pp. 285-291, 2000.
35. K. Pluta, M. J. Luce, L. Bao, S. Agha-Mohammadi, and J. Reiser, "Tight control of transgene expression by lentivirus vectors containing second-generation tetracycline-responsive promoters," The Journal of Gene Medicine, vol. 7, no. 6, pp. 803-817, 2005.
36. T. Yang, C. Burrows, and J. H. Park, "Development of a doxycycline- inducible lentiviral plasmid with an instant regulatory feature," Plasmid, vol. 72, no. 1, pp. 29-35, 2014.